Clinical Trial Update: Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the adjunctive use of mirabegron after the Rezum procedure for benign prostatic hyperplasia; the study status is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: University of Manitoba | Conditions: Benign Prostate Hypertrophy(BPH) | Phase 3 | Status: NOT_YET_RECRUITING